Global Hepatitis C virus testing market Size 2013-2017 | Forecast 2018-2024
Global Hepatitis C virus testing market Size 2013-2017 | Forecast 2018-2024
Know more about Hepatitis C virus and its market study
Global Hepatitis C virus testing market: Hepatitis C is a liver disease which is transmitted by the contact with the blood of an infected person. Hepatitis C show significant genetic variation in population worldwide, due to a high rate of viral RNA mutations. HCV has six variants (HCV genotypes 1, 2, 3, 4, 5, and 6), and 15 subtypes are recorded which vary in the rate of prevalence around the globe. Different types of devices are used for the diagnosis of hepatitis C virus, including HCV viral load test, HCV antibody test, HCV genotype test and liver biopsy. Inexpensive, rapid, robust, and sensitive analytical devices are essential for effective, accurate diagnosis and monitoring of disease treatment.
Increase in Hepatitis C virus testing Market is mainly attributed to a high incidence of chronic infection with Hepatitis C virus. Furthermore, unhygienic blood donation practices are the most dangerous and worrisome cause which leads to spreading of hepatitis C virus. Hepatitis C screening test is compulsory before organ donation, increase in organ donation globally expected to boost the testing market growth. The increase in healthcare expenditure, changing lifestyle and increase in government initiatives are some of the key factors driving the growth of global Hepatitis C virus antiviral testing Market. In addition, growing healthcare awareness about the Hepatitis C virus is also fueling the growth of global hepatitis C virus testing market. However, strict regulation for approval of hepatitis C testing is the major factor holding the growth of hepatitis C virus testing market.
Free sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-hepatitis-c-virus-testing-market/#ulp-4H8Z4LpNMLEuOnnx
The global Hepatitis C virus testing market is divided on the following topics-.
1. Techniques
• Polymerase Chain Reaction Tests
• Immunoassays
• Others
2. Tests
• Hepatitis C Antibody Test
• Hepatitis C RNA Quantitative Test
• Hepatitis C RNA Qualitative Test
• Hepatitis C RIBA
• Hepatitis C Genotype
• Viral Load
3. End-users
Hospital, diagnostic centers and blood donations centers.
Free TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-hepatitis-c-virus-testing-market/#ulp-c654SbFYO64MsOhu
And lastly, on the basis of geographical regions, Hepatitis C virus testing market is divided into Asia-Pacific, Latin America, North America, Europe and the Middle East and Africa. Europe Hepatitis C market is expected to grow at significant rate owing to increasing incidence of Hepatitis C virus diseases. According to WHO, European region has 1.5% and Eastern Mediterranean has 2.3% prevalence of HCV diseases that show significant variations in genes in population globally due to high rates of mutation of viral RNA. The Asia-Pacific is expected to be having lucrative market growth owing to disease prevalence rates.
Some of the key players in global Hepatitis C virus testing Market include Abbott Laboratories (U.S.), Bio Rad Laboratories Inc. (U.S.), Qiagen (Germany), Bayer AG (Switzerland), OraSure Technologies (U.S.), Siemens Healthcare GmbH (Germany), BioGenex (U.S.), H. Hoffman-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (U.S.), and Ortho Clinical Diagnostic Inc. (U.S.) among others. In 2017, Siemens Healthineer’s Versant HCV Genotype 2.0 line probe (LiPA) assay gained market approval from USFDA for HCV testing. While in 2015, Hologic received CE‐IVD certification for its Aptima® HCV (hepatitis C virus) Quant Dx assay on the fully automated Panther® system. Also back in 2010, OraQuick HCV Rapid Antibody Test was approved by the USFDA that became an alternative to enzyme immunoassay testing for HCV.
Ask Analyst for Full Information about this report @
https://www.precisionbusinessinsights.com/market-reports/global-hepatitis-c-virus-testing-market/#ulp-14mlyhjMGhVjZqa3
When compared to hepatitis A and hepatitis B Prevalence of hepatitis C is low. According to Institute of Liver and Biliary Sciences India (ILBS) around 3% of global population is infected with hepatitis C virus, therefore minimum R&D investments by market players to develop new and effective hepatitis C virus tests. Among all tests, HCV antibody testing is expected to occupy more share because antibody testing is the primarily used test for HCV testing. In the end-user segment, diagnostic centers are expected to have a major market share in HCV testing market. Application of new electrochemical immune sensor and genosensor technologies in HPV testing are expected to change conventional HPV testing practices.
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-hepatitis-c-virus-testing-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com